FIELD: biotechnology, biochemistry.
SUBSTANCE: invention can be used for isolation of proteins with necessary properties from large pools and nucleic acids. Invention involves preparing hybrids "RNA-protein" that involves stage of post-translation incubation with high concentration of monovalent cation. Cations Na+, K+ or NH+
4
are used as a monovalent cation in the concentration from 125 mM to 1.5 M. Method involves also using bivalence and/or the more high-valence cation, for example, Mg2+ in the concentration from 25 mM to 200 mM. Method provides preparing library of proteins. Similar method is used for preparing DNA library that involves additionally stage for generating DNA molecule from each RNA-moiety of hybrids. Invention discloses also method for selection of necessary protein and nucleic acid from prepared libraries of proteins and nucleic acids involving preparing and selection of required hybrid "RNA-protein" followed by selection of necessary protein and nucleic acid encoding the necessary protein. Using the invention provides alleviating the isolation of proteins with necessary properties and to solve the problem for isolation and amplification of protein sequence.
EFFECT: improved producing method.
43 cl, 5 tbl, 38 ex
Title |
Year |
Author |
Number |
METHOD FOR SELECTION OF DESIRABLE PROTEIN AND NUCLEIC ACID, AGENTS FOR ITS REALIZATION |
1998 |
- Zhostak Dzhek V.
- Roberts Richard V.
- Liu Rikhe
|
RU2233878C2 |
COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER |
2011 |
- Polakis Pol
- Asundi Dzhioti
- Fajrstejn Ron
- Kelli Robert F.
- Makkatcheon Krista
|
RU2595389C2 |
ANTIBODY AGAINST INTERFERON-α/β-BINDING PROTEIN I (IFNAB-BPI) |
1995 |
- Kokhen Batija
- Novik Daniela
- Rubinshtejn Menakhem
|
RU2363705C2 |
ANTIBODY AGAINST INTERFERON-ALPHA/BETA-CONNECTING PROTEIN II (IFNAB-BPII) |
1995 |
- Kokhen Batija
- Novik Daniela
- Rubinshtejn Menakhem
|
RU2362781C2 |
ISOLATED DNA MOLECULE ENCODING GLUCAGON RECEPTOR, DNA-CONSTRUCTION, CELL LINE, METHOD OF PREPARING GLUCAGON RECEPTOR, ISOLATED GLUCAGON RECEPTOR PEPTIDE, ISOLATED ANTIBODY, PROBE, METHOD OF DETECTION OF GLUCAGON ANTAGONIST PRESENCE |
1993 |
- Kindsvogl Vehjn R.
- Dzhelinek Laura Dzh.
- Sheppard Pol O.
- Grant Frehnsis Dzh.
- Kidzhper Dzhozef L.
- Foster Donald S.
- Lok Si
- O'Khara Patrik Dzh.
|
RU2184779C2 |
PROTEIN IFNAB-BPII ELICITING ABILITY TO BIND INTERFERON-α/β, ITS PRECURSOR AND FUSION PROTEINS, METHOD FOR PREPARING IFNAB-BPII, DNA MOLECULES, EXPRESSING VECTOR, PHARMACEUTICAL COMPOSITION |
1995 |
- Kokhen Batija
- Novik Daniela
- Rubinshtejn Menakhem
|
RU2232811C2 |
METHOD OF PREPARING PROTEIN EXHIBITING GM-CSF ACTIVITY OF PIMATES |
1985 |
- Stiven K.Klark
- Randal Dzh.Kaufman
- Gordon G.Vong
- Ehlizabet A.Vang
|
RU2130493C1 |
METHOD AND SET FOR DETECTING GENE ENCODING MEMBRANE-BOUND PROTEIN, VECTOR (VARIANTS) |
1999 |
- Tsutija Masajuki
- Saito Mikiesi
- Okhtomo Tosikhiko
|
RU2246538C2 |
METHOD OF PREPARING THE PROTEIN SHOWING FACTOR VII-MEDIATED ACTIVITY IN BLOOD COAGULATION |
1986 |
- Frederik S.Khejdzhen
- Mark Dzh.Murrej
- Sharon Dzh.Basbi
- Kehtlin L.Berkner
- Margaret I.Insli
- Richard G.Vudberi
- Charl'Z L.Grehj
|
RU2122583C1 |
COMPOSITION, METHOD FOR PRODUCING ARTIFICIAL ORDERED AND REPETITIONS-CONTAINING ANTIGEN MATRIX, METHOD FOR CARRYING OUT THERAPY AND IMMUNIZATION |
1999 |
- Bakhmann Martin
- Niba Lars
- Renner Vol'Fgang Eh.
- Khenneke Frank
|
RU2245163C2 |